Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Aug;115(7):1133–1140. doi: 10.1111/j.1476-5381.1995.tb15015.x

Effects of calcitonin gene-related peptide receptor antagonists on renal actions of adrenomedullin.

A M Elhawary 1, J Poon 1, C C Pang 1
PMCID: PMC1908781  PMID: 7582535

Abstract

1. Adrenomedullin is a novel vasoactive peptide which is produced in the lungs, ventricle, kidneys, heart and adrenal medulla. Adrenomedullin shows homology to calcitonin gene-related peptide (CGRP) and has similar pharmacological actions to CGRP. 2. This study examined the dose-response effects of adrenomedullin (rat, 11-50) on mean arterial pressure (MAP), heart rate (HR), renal blood flow (RBF), glomerular filtration rate (GFR) and renal tubular electrolyte excretion in Inactin-anaesthetized Sprague Dawley rats. The possible involvement of CGRP receptors in actions of adrenomedullin was also examined via renal arterial injection of a CGRP receptor antagonist, CGRP (8-37) (1 or 10 nmol kg-1) or [Tyr0]CGRP(28-37) (3 or 30 nmol kg-1), starting 15 min prior to the administration of adrenomedullin. 3. Renal arterial infusion (0.001 to 1 nmol kg-1) of adrenomedullin did not alter MAP, HR and renal K+ excretion but dose-dependently increased RBF and arterial conductance, GFR, urine flow and Na+ excretion. 4. The renal actions of adrenomedullin were not blocked by either the low or the high dose of CGRP(8-37) or [Tyr0]CGRP(28-37). 5. The results show that adrenomedullin causes renal vasodilatation, increments in GFR, diuresis and natriuresis. The renal actions of adrenomedullin are not mediated via the activation of CGRP1 receptors.

Full text

PDF
1133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castellucci A., Maggi C. A., Evangelista S. Calcitonin gene-related peptide (CGRP)1 receptor mediates vasodilation in the rat isolated and perfused kidney. Life Sci. 1993;53(9):PL153–PL158. doi: 10.1016/0024-3205(93)90254-z. [DOI] [PubMed] [Google Scholar]
  2. Chakder S., Rattan S. [Tyr0]-calcitonin gene-related peptide 28-37 (rat) as a putative antagonist of calcitonin gene-related peptide responses on opossum internal anal sphincter smooth muscle. J Pharmacol Exp Ther. 1990 Apr;253(1):200–206. [PubMed] [Google Scholar]
  3. Chiba T., Yamaguchi A., Yamatani T., Nakamura A., Morishita T., Inui T., Fukase M., Noda T., Fujita T. Calcitonin gene-related peptide receptor antagonist human CGRP-(8-37). Am J Physiol. 1989 Feb;256(2 Pt 1):E331–E335. doi: 10.1152/ajpendo.1989.256.2.E331. [DOI] [PubMed] [Google Scholar]
  4. Chin S. Y., Hall J. M., Brain S. D., Morton I. K. Vasodilator responses to calcitonin gene-related peptide (CGRP) and amylin in the rat isolated perfused kidney are mediated via CGRP1 receptors. J Pharmacol Exp Ther. 1994 Jun;269(3):989–992. [PubMed] [Google Scholar]
  5. Dennis T., Fournier A., Cadieux A., Pomerleau F., Jolicoeur F. B., St Pierre S., Quirion R. hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther. 1990 Jul;254(1):123–128. [PubMed] [Google Scholar]
  6. Dennis T., Fournier A., St Pierre S., Quirion R. Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther. 1989 Nov;251(2):718–725. [PubMed] [Google Scholar]
  7. Ebara T., Miura K., Okumura M., Matsuura T., Kim S., Yukimura T., Iwao H. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol. 1994 Sep 22;263(1-2):69–73. doi: 10.1016/0014-2999(94)90524-x. [DOI] [PubMed] [Google Scholar]
  8. Eguchi S., Hirata Y., Kano H., Sato K., Watanabe Y., Watanabe T. X., Nakajima K., Sakakibara S., Marumo F. Specific receptors for adrenomedullin in cultured rat vascular smooth muscle cells. FEBS Lett. 1994 Mar 7;340(3):226–230. doi: 10.1016/0014-5793(94)80143-6. [DOI] [PubMed] [Google Scholar]
  9. Elhawary A. M., Pang C. C. Renal vascular and tubular actions of calcitonin gene-related peptide: effect of NG-nitro-L-arginine methyl ester. J Pharmacol Exp Ther. 1995 Apr;273(1):56–63. [PubMed] [Google Scholar]
  10. Escott K. J., Brain S. D. Effect of a calcitonin gene-related peptide antagonist (CGRP8-37) on skin vasodilatation and oedema induced by stimulation of the rat saphenous nerve. Br J Pharmacol. 1993 Oct;110(2):772–776. doi: 10.1111/j.1476-5381.1993.tb13878.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gardiner S. M., Compton A. M., Kemp P. A., Bennett T., Bose C., Foulkes R., Hughes B. Antagonistic effect of human alpha-CGRP [8-37] on the in vivo regional haemodynamic actions of human alpha-CGRP. Biochem Biophys Res Commun. 1990 Sep 28;171(3):938–943. doi: 10.1016/0006-291x(90)90774-h. [DOI] [PubMed] [Google Scholar]
  12. Gardiner S. M., Kemp P. A., March J. E., Bennett T. Regional haemodynamic effects of human and rat adrenomedullin in conscious rats. Br J Pharmacol. 1995 Feb;114(3):584–591. doi: 10.1111/j.1476-5381.1995.tb17179.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Han S. P., Naes L., Westfall T. C. Inhibition of periarterial nerve stimulation-induced vasodilation of the mesenteric arterial bed by CGRP (8-37) and CGRP receptor desensitization. Biochem Biophys Res Commun. 1990 Apr 30;168(2):786–791. doi: 10.1016/0006-291x(90)92390-l. [DOI] [PubMed] [Google Scholar]
  14. Hughes S. R., Brain S. D. A calcitonin gene-related peptide (CGRP) antagonist (CGRP8-37) inhibits microvascular responses induced by CGRP and capsaicin in skin. Br J Pharmacol. 1991 Nov;104(3):738–742. doi: 10.1111/j.1476-5381.1991.tb12497.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ichiki Y., Kitamura K., Kangawa K., Kawamoto M., Matsuo H., Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 1994 Jan 24;338(1):6–10. doi: 10.1016/0014-5793(94)80106-1. [DOI] [PubMed] [Google Scholar]
  16. Ishiyama Y., Kitamura K., Ichiki Y., Nakamura S., Kida O., Kangawa K., Eto T. Hemodynamic effects of a novel hypotensive peptide, human adrenomedullin, in rats. Eur J Pharmacol. 1993 Sep 14;241(2-3):271–273. doi: 10.1016/0014-2999(93)90214-3. [DOI] [PubMed] [Google Scholar]
  17. Ishizaka Y., Ishizaka Y., Tanaka M., Kitamura K., Kangawa K., Minamino N., Matsuo H., Eto T. Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun. 1994 Apr 15;200(1):642–646. doi: 10.1006/bbrc.1994.1496. [DOI] [PubMed] [Google Scholar]
  18. Kitamura K., Ichiki Y., Tanaka M., Kawamoto M., Emura J., Sakakibara S., Kangawa K., Matsuo H., Eto T. Immunoreactive adrenomedullin in human plasma. FEBS Lett. 1994 Mar 21;341(2-3):288–290. doi: 10.1016/0014-5793(94)80474-5. [DOI] [PubMed] [Google Scholar]
  19. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H., Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun. 1993 Apr 30;192(2):553–560. doi: 10.1006/bbrc.1993.1451. [DOI] [PubMed] [Google Scholar]
  20. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem Biophys Res Commun. 1993 Jul 30;194(2):720–725. doi: 10.1006/bbrc.1993.1881. [DOI] [PubMed] [Google Scholar]
  21. Leyssac P. P., Karlsen F. M., Skøtt O. Dynamics of intrarenal pressures and glomerular filtration rate after acetazolamide. Am J Physiol. 1991 Jul;261(1 Pt 2):F169–F178. doi: 10.1152/ajprenal.1991.261.1.F169. [DOI] [PubMed] [Google Scholar]
  22. Maton P. N., Pradhan T., Zhou Z. C., Gardner J. D., Jensen R. T. Activities of calcitonin gene-related peptide (CGRP) and related peptides at the CGRP receptor. Peptides. 1990 May-Jun;11(3):485–489. doi: 10.1016/0196-9781(90)90047-9. [DOI] [PubMed] [Google Scholar]
  23. Mimeault M., Fournier A., Dumont Y., St-Pierre S., Quirion R. Comparative affinities and antagonistic potencies of various human calcitonin gene-related peptide fragments on calcitonin gene-related peptide receptors in brain and periphery. J Pharmacol Exp Ther. 1991 Sep;258(3):1084–1090. [PubMed] [Google Scholar]
  24. Nuki C., Kawasaki H., Kitamura K., Takenaga M., Kangawa K., Eto T., Wada A. Vasodilator effect of adrenomedullin and calcitonin gene-related peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun. 1993 Oct 15;196(1):245–251. doi: 10.1006/bbrc.1993.2241. [DOI] [PubMed] [Google Scholar]
  25. Perret M., Broussard H., LeGros T., Burns A., Chang J. K., Summer W., Hyman A., Lippton H. The effect of adrenomedullin on the isolated heart. Life Sci. 1993;53(22):PL377–PL379. doi: 10.1016/0024-3205(93)90213-m. [DOI] [PubMed] [Google Scholar]
  26. Poyner D. R. Calcitonin gene-related peptide: multiple actions, multiple receptors. Pharmacol Ther. 1992;56(1):23–51. doi: 10.1016/0163-7258(92)90036-y. [DOI] [PubMed] [Google Scholar]
  27. Preibisz J. J. Calcitonin gene-related peptide and regulation of human cardiovascular homeostasis. Am J Hypertens. 1993 May;6(5 Pt 1):434–450. doi: 10.1093/ajh/6.5.434. [DOI] [PubMed] [Google Scholar]
  28. Rovero P., Giuliani S., Maggi C. A. CGRP antagonist activity of short C-terminal fragments of human alpha CGRP, CGRP(23-37) and CGRP(19-37). Peptides. 1992 Sep-Oct;13(5):1025–1027. doi: 10.1016/0196-9781(92)90067-d. [DOI] [PubMed] [Google Scholar]
  29. Sakata J., Shimokubo T., Kitamura K., Nakamura S., Kangawa K., Matsuo H., Eto T. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun. 1993 Sep 15;195(2):921–927. doi: 10.1006/bbrc.1993.2132. [DOI] [PubMed] [Google Scholar]
  30. Smits J. F., Kasbergen C. M., van Essen H., Kleinjans J. C., Struyker-Boudier H. A. Chronic local infusion into the renal artery of unrestrained rats. Am J Physiol. 1983 Feb;244(2):H304–H307. doi: 10.1152/ajpheart.1983.244.2.H304. [DOI] [PubMed] [Google Scholar]
  31. Stacy B. D., Thorburn G. D. Chromium-51 ethylenediaminetetraacetate for estimation of globerular filtration rate. Science. 1966 May 20;152(3725):1076–1077. doi: 10.1126/science.152.3725.1076. [DOI] [PubMed] [Google Scholar]
  32. Takahashi H., Watanabe T. X., Nishimura M., Nakanishi T., Sakamoto M., Yoshimura M., Komiyama Y., Masuda M., Murakami T. Centrally induced vasopressor and sympathetic responses to a novel endogenous peptide, adrenomedullin, in anesthetized rats. Am J Hypertens. 1994 May;7(5):478–482. doi: 10.1093/ajh/7.5.478. [DOI] [PubMed] [Google Scholar]
  33. Wei E. P., Moskowitz M. A., Boccalini P., Kontos H. A. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ Res. 1992 Jun;70(6):1313–1319. doi: 10.1161/01.res.70.6.1313. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES